10-QPeriod: Q3 FY2024

HCA Healthcare, Inc. Quarterly Report for Q3 Ended Sep 30, 2024

Filed October 31, 2024For Securities:HCA

Summary

HCA Healthcare, Inc. reported a strong third quarter of 2024, with revenues increasing by 7.9% to $17.487 billion and net income attributable to HCA Healthcare, Inc. rising by 17.7% to $1.270 billion ($4.88 per diluted share). This growth was driven by a combination of increased patient volumes, with equivalent admissions up 5.0%, and higher revenue per equivalent admission, up 2.8%. The company also saw a significant improvement in operating cash flow, which increased by $1.036 billion to $3.515 billion for the quarter, primarily due to favorable changes in working capital. Despite facing headwinds such as inflationary pressures on supplies and other operating expenses, and incurring approximately $50 million in losses and additional expenses related to Hurricane Helene, HCA Healthcare demonstrated resilience. The company has proactively managed labor costs, with a notable 17.8% decline in contract labor costs year-over-year. Looking ahead, HCA Healthcare anticipates further impacts from hurricanes Milton and Helene in the fourth quarter, estimated between $200 million and $300 million, but continues its strategic capital allocation through significant share repurchases and dividend payments, signaling confidence in its financial position.

Financial Statements
Beta
Revenue$17.49B
Operating Expenses$15.58B
Interest Expense$515.00M
Net Income$1.27B
EPS (Basic)$4.94
EPS (Diluted)$4.88
Shares Outstanding (Basic)256.76M
Shares Outstanding (Diluted)259.92M

Key Highlights

  • 1Revenue increased 7.9% year-over-year to $17.487 billion in Q3 2024, driven by a 5.0% rise in equivalent admissions and a 2.8% increase in revenue per equivalent admission.
  • 2Net income attributable to HCA Healthcare, Inc. grew 17.7% to $1.270 billion ($4.88 per diluted share) in Q3 2024, compared to $1.079 billion ($3.91 per diluted share) in Q3 2023.
  • 3Operating cash flow saw a substantial increase of $1.036 billion, reaching $3.515 billion in Q3 2024, largely due to improved working capital management.
  • 4The company reported a significant reduction in contract labor costs (17.8% decrease year-over-year), contributing to improved labor cost management.
  • 5HCA Healthcare incurred approximately $50 million in losses and additional expenses related to Hurricane Helene in Q3 2024, with an estimated $200-$300 million impact anticipated for Q4 2024 due to Hurricanes Helene and Milton.
  • 6Share repurchases remain a focus, with $4.949 million shares repurchased in Q3 2024 for approximately $1.79 billion, and $2.433 billion of repurchase authorization remaining as of September 30, 2024.
  • 7The company anticipates capital expenditures of approximately $5 billion for the full year 2024, with ongoing projects estimated at $4.7 billion over the next five years.

Frequently Asked Questions

Revenue growth was primarily driven by a combination of increased patient volumes and higher revenue per equivalent admission. Specifically, equivalent admissions increased by 5.0%, and revenue per equivalent admission rose by 2.8% compared to the same period in the prior year.

HCA Healthcare reported a favorable impact on salaries and benefits, partly due to a significant 17.8% decline in contract labor costs year-over-year during the third quarter of 2024. While total salaries and benefits as a percentage of revenue slightly increased, the reduction in contract labor suggests improved cost control in this area.

In the third quarter of 2024, HCA Healthcare incurred approximately $50 million in losses and additional expenses related to Hurricane Helene. The company anticipates a further impact in the fourth quarter of 2024, estimated between $200 million and $300 million, due to the combined effects of Hurricane Helene and Hurricane Milton. These estimates do not include any potential insurance recoveries.

HCA Healthcare continues to actively engage in capital allocation through share repurchases and dividends. In the third quarter of 2024, the company repurchased approximately 4.95 million shares of common stock. Additionally, the board declared a quarterly dividend of $0.66 per share. The company also plans substantial capital expenditures, expecting to spend approximately $5 billion in 2024 on its facilities.